CapsoVision, Inc. focuses on transforming the detection and diagnosis of gastrointestinal diseases through its innovative capsule endoscopy systems. The company's primary offering, the CapsoCam Plus system, includes a single-use capsule and the CapsoCloud and CapsoView software, enabling healthcare providers to panoramically visualize the small-bowel mucosa for conditions like obscure GI bleeding and Crohn's disease. CapsoVision is also developing pipeline products such as CapsoCam Colon for non-invasive colon imaging and polyp detection. The company's solutions are designed to eliminate the need for capital equipment, allowing for remote ingestion and streamlined clinical operations. Headquartered in Silicon Valley, CapsoVision serves gastrointestinal medical practices, clinics, and hospitals primarily through distributor networks.
